The fund raised $225 million from investors including academic health systems, university endowments, foundations and family offices, among other institutional investors. Vensana will use the fund to invest in companies in the clinical development and commercialization stages, with a focus on those developing medical devices, diagnostics and data science, drug delivery, digital health and tech-enabled services.
Vensana was co-founded by managing partners Kirk Nielsen and Justin Klein, MD, who, along with the rest of the Vensana staff, have a history of investing in innovative medtech companies such as CardiAQ, Cartiva, CV Ingenuity and more.
More articles on innovation:
America’s Most Innovative Leaders: 24 healthcare leaders on the list
3 strategies that slow, rather than speed, innovation
7 key quotes about hospital innovation
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
